Solventum Corp. (SOLV)
91.75
+0.50
(+0.55%)
USD |
NYSE |
Aug 25, 15:36
Solventum Cash from Operations (Quarterly) : 227.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 227.00M |
| March 31, 2026 | -189.00M |
| December 31, 2025 | 95.00M |
| September 30, 2025 | 76.00M |
| June 30, 2025 | 169.00M |
| March 31, 2025 | 35.00M |
| December 31, 2024 | 219.00M |
| Date | Value |
|---|---|
| September 30, 2024 | 169.00M |
| June 30, 2024 | 355.00M |
| March 31, 2024 | 442.00M |
| December 31, 2023 | 547.00M |
| September 30, 2023 | 493.00M |
| June 30, 2023 | 366.00M |
| March 31, 2023 | 509.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Stryker Corp. | 1.261B |
| Zimmer Biomet Holdings, Inc. | 447.80M |
| Edwards Lifesciences Corp. | 651.90M |
| Intuitive Surgical, Inc. | 1.061B |
| Inspire Medical Systems, Inc. | 23.23M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -87.00M |
| Cash from Financing (Quarterly) | -300.00M |
| Free Cash Flow | -118.00M |
| Free Cash Flow Per Share (Quarterly) | 0.8309 |
| Free Cash Flow to Equity (Quarterly) | 145.00M |
| Free Cash Flow to Firm (Quarterly) | 199.11M |
| Free Cash Flow Yield | -0.73% |